Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410565

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410565

Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

PUBLISHED:
PAGES: 409 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

The global peripheral vascular devices market is on an upward trajectory, projected to propel it to a valuation of US$ 8.6 billion by the end of 2031, according to the latest report by Fairfield Market Research. In 2024, the market generated revenues of US$ 4.9 billion, with peripheral vascular stents accounting for a substantial portion.

Increased Volume of Surgeries & Accessibility to Reimbursements Driving Growth

One of the key factors driving the expansion of the peripheral vascular devices market is the increasing volume of surgeries and improved access to reimbursements. The rise in outpatient procedures for peripheral vascular interventions, particularly in developed countries, is attributed to modifications in reimbursement policies and government initiatives. This trend is expected to continue, fostering market growth.

Rising Number of End Users Fueling Market Expansion

The market is further buoyed by the growing number of ambulatory surgical centers (ASCs) in both underdeveloped and developing nations. The proliferation of ASCs is expected to lead to an increase in outpatient cases, thereby driving overall market expansion.

Challenges Due to Product Recalls

While the peripheral vascular devices market is on an upward trajectory, challenges exist, including an increasing threat of product recalls. The development of new and innovative technologies has led to some products being recalled by regulatory bodies like the Food and Drug Administration (FDA) due to serious adverse health consequences. Factors such as deployment issues, bleeding, and strokes pose potential risks and may restrain market growth to some extent.

Country-wise Insights: The U.S., Germany, and China

  • The Lucrative U.S. Market: The United States accounted for 94.5% of the North American peripheral vascular devices market. The U.S. market benefits from ongoing development, innovation in technology, and the growing use of drug-eluting stents in interventional procedures.
  • Germany's Stance: Germany held a significant share in the European peripheral vascular devices market. The country's focus on research and development, coupled with its quick adoption of healthcare technologies, positions it as a prominent player in the market.
  • China Emerges Strong: China dominated the East Asia peripheral vascular devices market. The rising prevalence of diabetes and an aging population in China are driving the demand for peripheral vascular devices.

Competitive Analysis and Key Players

Leading manufacturers in the peripheral vascular devices industry are actively developing technologically-advanced products to strengthen their global portfolios. Mergers, acquisitions, expansions, and collaborations are common strategies employed by key players to enhance their market share.

Key Companies Profiled:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Peripheral Vascular Devices Industry Research Segmentation

By Product:

  • Peripheral Vascular Stents

Self-Expanding Stents

Balloon Expanding Stents

Covered Stents

Drug Eluting Stents

  • Drug Eluting Balloons
  • Peripheral Vascular Bioresorbable Scaffolds

By Indication:

  • Target Artery Instability (TAI)
  • Access Artery Injury (AAI)
  • Peripheral Arterial Disease
  • Arteriovenous Fistulas
  • Peripheral Aneurysms
  • Others

By Artery Type:

  • Carotid Artery
  • Fem-Pop Artery
  • Iliac Artery
  • Infrapop Artery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Peripheral Vascular Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Peripheral Vascular Devices Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Peripheral Vascular Devices Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Peripheral Vascular Devices Market Outlook, 2018 - 2031

  • 5.1. Global Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Peripheral Vascular Stents
        • 5.1.1.1.1. Self-Expanding Stents
        • 5.1.1.1.2. Balloon Expanding Stents
        • 5.1.1.1.3. Covered Stents
        • 5.1.1.1.4. Drug Eluting Stents
      • 5.1.1.2. Drug Eluting Balloons
      • 5.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
  • 5.2. Global Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Target Artery Instability (TAI)
      • 5.2.1.2. Access Artery Injury (AAI)
      • 5.2.1.3. Peripheral Arterial Disease
      • 5.2.1.4. Arteriovenous Fistulas
      • 5.2.1.5. Peripheral Aneurysms
      • 5.2.1.6. Others
  • 5.3. Global Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Carotid Artery
      • 5.3.1.2. Fem-Pop Artery
      • 5.3.1.3. Iliac Artery
      • 5.3.1.4. Infrapop Artery
  • 5.4. Global Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Ambulatory Surgical Centers/Outpatients
      • 5.4.1.3. Cardiac Catheterization Labs
  • 5.5. Global Peripheral Vascular Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. North America
      • 5.5.1.2. Europe
      • 5.5.1.3. Asia Pacific
      • 5.5.1.4. Latin America
      • 5.5.1.5. Middle East & Africa

6. North America Peripheral Vascular Devices Market Outlook, 2018 - 2031

  • 6.1. North America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Peripheral Vascular Stents
        • 6.1.1.1.1. Self-Expanding Stents
        • 6.1.1.1.2. Balloon Expanding Stents
        • 6.1.1.1.3. Covered Stents
        • 6.1.1.1.4. Drug Eluting Stents
      • 6.1.1.2. Drug Eluting Balloons
      • 6.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
  • 6.2. North America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Target Artery Instability (TAI)
      • 6.2.1.2. Access Artery Injury (AAI)
      • 6.2.1.3. Peripheral Arterial Disease
      • 6.2.1.4. Arteriovenous Fistulas
      • 6.2.1.5. Peripheral Aneurysms
      • 6.2.1.6. Others
  • 6.3. North America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Carotid Artery
      • 6.3.1.2. Fem-Pop Artery
      • 6.3.1.3. Iliac Artery
      • 6.3.1.4. Infrapop Artery
  • 6.4. North America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Ambulatory Surgical Centers/Outpatients
      • 6.4.1.3. Cardiac Catheterization Labs
  • 6.5. North America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. U.S. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.2. U.S. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.3. U.S. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.4. U.S. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.5. Canada Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.6. Canada Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.7. Canada Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.5.1.8. Canada Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Peripheral Vascular Devices Market Outlook, 2018 - 2031

  • 7.1. Europe Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Peripheral Vascular Stents
        • 7.1.1.1.1. Self-Expanding Stents
        • 7.1.1.1.2. Balloon Expanding Stents
        • 7.1.1.1.3. Covered Stents
        • 7.1.1.1.4. Drug Eluting Stents
      • 7.1.1.2. Drug Eluting Balloons
      • 7.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
  • 7.2. Europe Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Target Artery Instability (TAI)
      • 7.2.1.2. Access Artery Injury (AAI)
      • 7.2.1.3. Peripheral Arterial Disease
      • 7.2.1.4. Arteriovenous Fistulas
      • 7.2.1.5. Peripheral Aneurysms
      • 7.2.1.6. Others
  • 7.3. Europe Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Carotid Artery
      • 7.3.1.2. Fem-Pop Artery
      • 7.3.1.3. Iliac Artery
      • 7.3.1.4. Infrapop Artery
  • 7.4. Europe Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Ambulatory Surgical Centers/Outpatients
      • 7.4.1.3. Cardiac Catheterization Labs
  • 7.5. Europe Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Germany Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.2. Germany Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.3. Germany Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.4. Germany Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.5. U.K. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.6. U.K. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.7. U.K. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.8. U.K. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.9. France Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.10. France Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.11. France Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.12. France Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.13. Italy Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.14. Italy Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.15. Italy Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.16. Italy Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.17. Turkey Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.18. Turkey Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.19. Turkey Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.20. Turkey Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.21. Russia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.22. Russia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.23. Russia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.24. Russia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.25. Rest of Europe Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.26. Rest of Europe Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.27. Rest of Europe Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.5.1.28. Rest of Europe Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Peripheral Vascular Devices Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Peripheral Vascular Stents
        • 8.1.1.1.1. Self-Expanding Stents
        • 8.1.1.1.2. Balloon Expanding Stents
        • 8.1.1.1.3. Covered Stents
        • 8.1.1.1.4. Drug Eluting Stents
      • 8.1.1.2. Drug Eluting Balloons
      • 8.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
  • 8.2. Asia Pacific Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Target Artery Instability (TAI)
      • 8.2.1.2. Access Artery Injury (AAI)
      • 8.2.1.3. Peripheral Arterial Disease
      • 8.2.1.4. Arteriovenous Fistulas
      • 8.2.1.5. Peripheral Aneurysms
      • 8.2.1.6. Others
  • 8.3. Asia Pacific Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Carotid Artery
      • 8.3.1.2. Fem-Pop Artery
      • 8.3.1.3. Iliac Artery
      • 8.3.1.4. Infrapop Artery
  • 8.4. Asia Pacific Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Ambulatory Surgical Centers/Outpatients
      • 8.4.1.3. Cardiac Catheterization Labs
  • 8.5. Asia Pacific Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. China Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.2. China Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.3. China Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.4. China Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.5. Japan Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.6. Japan Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.7. Japan Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.8. Japan Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.9. South Korea Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.10. South Korea Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.11. South Korea Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.12. South Korea Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.13. India Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.14. India Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.15. India Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.16. India Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.17. Southeast Asia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.18. Southeast Asia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.19. Southeast Asia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.20. Southeast Asia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.21. Rest of Asia Pacific Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.22. Rest of Asia Pacific Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.23. Rest of Asia Pacific Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.5.1.24. Rest of Asia Pacific Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Peripheral Vascular Devices Market Outlook, 2018 - 2031

  • 9.1. Latin America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Peripheral Vascular Stents
        • 9.1.1.1.1. Self-Expanding Stents
        • 9.1.1.1.2. Balloon Expanding Stents
        • 9.1.1.1.3. Covered Stents
        • 9.1.1.1.4. Drug Eluting Stents
      • 9.1.1.2. Drug Eluting Balloons
      • 9.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
  • 9.2. Latin America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Target Artery Instability (TAI)
      • 9.2.1.2. Access Artery Injury (AAI)
      • 9.2.1.3. Peripheral Arterial Disease
      • 9.2.1.4. Arteriovenous Fistulas
      • 9.2.1.5. Peripheral Aneurysms
      • 9.2.1.6. Others
  • 9.3. Latin America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Carotid Artery
      • 9.3.1.2. Fem-Pop Artery
      • 9.3.1.3. Iliac Artery
      • 9.3.1.4. Infrapop Artery
  • 9.4. Latin America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Ambulatory Surgical Centers/Outpatients
      • 9.4.1.3. Cardiac Catheterization Labs
  • 9.5. Latin America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.5.1. Key Highlights
      • 9.5.1.1. Brazil Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.2. Brazil Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.3. Brazil Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.4. Brazil Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.5. Mexico Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.6. Mexico Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.7. Mexico Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.8. Mexico Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.9. Argentina Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.10. Argentina Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.11. Argentina Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.12. Argentina Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.13. Rest of Latin America Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.14. Rest of Latin America Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.15. Rest of Latin America Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.5.1.16. Rest of Latin America Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.5.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Peripheral Vascular Devices Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Peripheral Vascular Stents
        • 10.1.1.1.1. Self-Expanding Stents
        • 10.1.1.1.2. Balloon Expanding Stents
        • 10.1.1.1.3. Covered Stents
        • 10.1.1.1.4. Drug Eluting Stents
      • 10.1.1.2. Drug Eluting Balloons
      • 10.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
  • 10.2. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Target Artery Instability (TAI)
      • 10.2.1.2. Access Artery Injury (AAI)
      • 10.2.1.3. Peripheral Arterial Disease
      • 10.2.1.4. Arteriovenous Fistulas
      • 10.2.1.5. Peripheral Aneurysms
      • 10.2.1.6. Others
  • 10.3. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Carotid Artery
      • 10.3.1.2. Fem-Pop Artery
      • 10.3.1.3. Iliac Artery
      • 10.3.1.4. Infrapop Artery
  • 10.4. Middle East & Africa Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. Hospitals
      • 10.4.1.2. Ambulatory Surgical Centers/Outpatients
      • 10.4.1.3. Cardiac Catheterization Labs
  • 10.5. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.5.1. Key Highlights
      • 10.5.1.1. GCC Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.2. GCC Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.3. GCC Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.4. GCC Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.5. South Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.6. South Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.7. South Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.8. South Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.9. Egypt Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.10. Egypt Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.11. Egypt Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.12. Egypt Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.13. Nigeria Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.14. Nigeria Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.15. Nigeria Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.16. Nigeria Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.17. Rest of Middle East & Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.18. Rest of Middle East & Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.19. Rest of Middle East & Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.5.1.20. Rest of Middle East & Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.5.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. Product vs Indication Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Abbott Laboratories
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Boston Scientific Corporation
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Cook Medical Inc.
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. MicroPort Scientific Corporation (Endovastec™)
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Medtronic Plc.
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Cardinal Health, Inc
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. B. Braun Melsungen AG
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. BIOTRONIK SE & Co. KG
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Becton, Dickinson, and Company
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. W. L. Gore & Associates Inc.
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Product Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Getinge AB
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Product Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development
    • 11.4.12. Terumo Corp
      • 11.4.12.1. Company Overview
      • 11.4.12.2. Product Portfolio
      • 11.4.12.3. Financial Overview
      • 11.4.12.4. Business Strategies and Development
    • 11.4.13. Kyoto Medical Planning Co Ltd
      • 11.4.13.1. Company Overview
      • 11.4.13.2. Product Portfolio
      • 11.4.13.3. Financial Overview
      • 11.4.13.4. Business Strategies and Development
    • 11.4.14. iVascular S.L.U
      • 11.4.14.1. Company Overview
      • 11.4.14.2. Product Portfolio
      • 11.4.14.3. Financial Overview
      • 11.4.14.4. Business Strategies and Development
    • 11.4.15. AMG International GmbH
      • 11.4.15.1. Company Overview
      • 11.4.15.2. Product Portfolio
      • 11.4.15.3. Financial Overview
      • 11.4.15.4. Business Strategies and Development
    • 11.4.16. Endocor GmbH
      • 11.4.16.1. Company Overview
      • 11.4.16.2. Product Portfolio
      • 11.4.16.3. Financial Overview
      • 11.4.16.4. Business Strategies and Development
    • 11.4.17. Meril Life Sciences Pvt. Ltd.
      • 11.4.17.1. Company Overview
      • 11.4.17.2. Product Portfolio
      • 11.4.17.3. Financial Overview
      • 11.4.17.4. Business Strategies and Development
    • 11.4.18. Nano Therapeutics Pvt Ltd
      • 11.4.18.1. Company Overview
      • 11.4.18.2. Product Portfolio
      • 11.4.18.3. Financial Overview
      • 11.4.18.4. Business Strategies and Development
    • 11.4.19. Koninklijke Philips N.V.
      • 11.4.19.1. Company Overview
      • 11.4.19.2. Product Portfolio
      • 11.4.19.3. Financial Overview
      • 11.4.19.4. Business Strategies and Development
    • 11.4.20. REVA Medical
      • 11.4.20.1. Company Overview
      • 11.4.20.2. Product Portfolio
      • 11.4.20.3. Financial Overview
      • 11.4.20.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!